Burning Rock Biotech Ltd. (BNR)
11.63
+0.48
(+4.30%)
USD |
NASDAQ |
Oct 27, 13:11
Burning Rock Biotech Enterprise Value : 42.84M for Oct. 26, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 42.84M |
| October 23, 2026 | 48.73M |
| October 22, 2026 | 61.29M |
| October 21, 2026 | 63.58M |
| October 20, 2026 | 56.11M |
| October 19, 2026 | 52.86M |
| October 16, 2026 | 58.22M |
| October 15, 2026 | 81.94M |
| October 14, 2026 | 73.24M |
| October 13, 2026 | 76.67M |
| October 12, 2026 | 76.67M |
| October 09, 2026 | 80.97M |
| October 08, 2026 | 78.43M |
| October 07, 2026 | 78.25M |
| October 06, 2026 | 86.42M |
| October 05, 2026 | 83.92M |
| October 02, 2026 | 87.65M |
| October 01, 2026 | 85.37M |
| September 30, 2026 | 99.78M |
| September 29, 2026 | 111.29M |
| September 28, 2026 | 99.78M |
| September 25, 2026 | 108.30M |
| September 24, 2026 | 103.03M |
| September 23, 2026 | 77.33M |
| September 22, 2026 | 89.41M |
| Date | Value |
|---|---|
| September 21, 2026 | 74.30M |
| September 18, 2026 | 69.95M |
| September 17, 2026 | 63.67M |
| September 16, 2026 | 54.88M |
| September 15, 2026 | 47.50M |
| September 14, 2026 | 46.80M |
| September 11, 2026 | 52.77M |
| September 10, 2026 | 46.97M |
| September 09, 2026 | 50.22M |
| September 08, 2026 | 38.98M |
| September 04, 2026 | 50.22M |
| September 03, 2026 | 39.59M |
| September 02, 2026 | 25.27M |
| September 01, 2026 | 25.89M |
| August 31, 2026 | 27.91M |
| August 28, 2026 | 34.41M |
| August 27, 2026 | 32.74M |
| August 26, 2026 | 36.61M |
| August 25, 2026 | 30.98M |
| August 24, 2026 | 35.55M |
| August 21, 2026 | 30.81M |
| August 20, 2026 | 26.15M |
| August 19, 2026 | 30.90M |
| August 18, 2026 | 26.68M |
| August 17, 2026 | 24.83M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 670.81M |
| BioRestorative Therapies, Inc. | -1.545M |
| CareDx, Inc. | 3.203B |
| Natera, Inc. | 57.30B |
| WuXi AppTec Co., Ltd. | 8.202B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.705M |
| Revenue (Quarterly) | 19.80M |
| Total Expenses (Quarterly) | 22.50M |
| EPS Diluted (Quarterly) | -0.249 |
| Gross Profit Margin (Quarterly) | 72.58% |
| Profit Margin (Quarterly) | -13.66% |
| Earnings Yield | -7.85% |
| Normalized Earnings Yield | -7.846 |